Clinical Trials Directory

Trials / Completed

CompletedNCT05006924

Symptoms and Outcome Measures for Upper- Limb Function in Myotonic Dystrophy Type 1

Status
Completed
Phase
Study type
Observational
Enrollment
89 (actual)
Sponsor
Oslo University Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Myotonic Dystrophy type 1 (DM1) is a multisystem disease that causes muscle weakness and myotonia. As a result upper limb function might become impaired. In this study we will examine patients with DM1 and record their upper limb function. We will will use a battery of patient reported outcomes (PROs) and Outcome measures (OMs) in order to evalute which ones are suitable for use in clinical practise and research studies.

Conditions

Timeline

Start date
2021-12-10
Primary completion
2024-08-31
Completion
2024-08-31
First posted
2021-08-16
Last updated
2025-04-27

Locations

3 sites across 1 country: Norway

Source: ClinicalTrials.gov record NCT05006924. Inclusion in this directory is not an endorsement.

Symptoms and Outcome Measures for Upper- Limb Function in Myotonic Dystrophy Type 1 (NCT05006924) · Clinical Trials Directory